TXNIP and metabolic dysfunction-associated steatohepatitis: Studies have shown that TXNIP knockdown can upregulate the expression of tight junction protein ZO-1 and occluding in intestinal epithelial cells of mice with non-alcoholic steatohepatitis, reduce MPO activity and ROS levels, and reduce hepatitis-induced intestinal mucosal injury [43,44].